Cargando…

Cytoreductive nephrectomy in the current treatment algorithm

The two recent prospective randomized trials CARMENA and SURTIME have changed the therapy paradigm of metastatic renal cell carcinoma. The CARMENA trial was conducted to investigate whether cytoreductive nephrectomy (CN) is required in the targeted therapy area, whereas SURTIME studied whether defer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuusk, Teele, Szabados, Bernadett, Liu, Wing Kin, Powles, Thomas, Bex, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Challenging Dogma: New Evidence to Guide Practice in Urologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767741/ https://www.ncbi.nlm.nih.gov/pubmed/31632471 http://dx.doi.org/10.1177/1758835919879026

Ejemplares similares

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?
por: Alipour, Ramin, et al.
Publicado: (2019)

Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma
por: Rassy, Elie, et al.
Publicado: (2020)

PARP inhibitor combinations in prostate cancer
por: Pezaro, Carmel
Publicado: (2020)

Tivozanib in renal cell carcinoma: a new approach to previously treated disease
por: Salgia, Nicholas J., et al.
Publicado: (2020)

Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
por: Davis, Ian D.
Publicado: (2022)

Cost-effectiveness of enfortumab vedotin in previously treated advanced urothelial carcinoma
por: Wu, Qiuji, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
por: Bex, A, et al.
Publicado: (2020)

Is laparoscopic approach safe for radical nephrectomy for tumors larger than 7 cm?
por: Jain, Paresh, et al.
Publicado: (2008)

A hands-on tutorial on network and topological neuroscience
por: Centeno, Eduarda Gervini Zampieri, et al.
Publicado: (2022)

Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy
por: Ziegelmueller, Brigitte K, et al.
Publicado: (2019)

Radical or simple nephrectomy in localized renal cell carcinoma: what is a choice?
por: Shulyak, Alexander, et al.
Publicado: (2011)

Impact of hospital nephrectomy volume on intermediate‐ to long‐term survival in renal cell carcinoma
por: Hsu, Ray C. J., et al.
Publicado: (2019)

Laparoscopic Nephrectomy in Patients with Previous Abdominal Surgery
por: Breish, Mohamed O, et al.
Publicado: (2020)

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment
por: Meerveld-Eggink, Aafke, et al.
Publicado: (2022)

Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000–2010
por: Hsu, Ray C. J., et al.
Publicado: (2018)

Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors
por: Szabados, Bernadett, et al.
Publicado: (2020)

Factors Affecting Robotic Partial Nephrectomy Conversion to Radical Nephrectomy: A Retrospective Multi-Institutional Analysis in the Michigan Urologic Surgery Improvement Collaborative (MUSIC)
por: Goldman, Benjamin, et al.
Publicado: (2021)

Three Different Learning Curves Have an Independent Impact on Perioperative Outcomes After Robotic Partial Nephrectomy: A Comparative Analysis
por: Zeuschner, Philip, et al.
Publicado: (2020)

Bilateral Renal Oncocytoma: Active Surveillance Versus Partial Nephrectomy
por: Sathe, Abha, et al.
Publicado: (2022)

Risk Factors for Atelectasis or Pneumomediastinum After Robot-Assisted Partial Nephrectomy
por: Yano, Fumiakira, et al.
Publicado: (2021)

Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease
por: Blok, Joost M., et al.
Publicado: (2019)

An Unusual and Rare Metachronous Ipsilateral Ureteric Stump Metastasis Post Radical Nephrectomy
por: Chalokia, Ramandeep, et al.
Publicado: (2021)

SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking?
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 10: Taking equity into consideration when assessing the findings of a systematic review
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed Policymaking in health 11: Finding and using evidence about local conditions
por: Lewin, Simon, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 12: Finding and using research evidence about resource use and costs
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for Evidence-informed Policymaking in health 18: Planning monitoring and evaluation of policies
por: Fretheim, Atle, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for Evidence-informed Policymaking in health 6: Using research evidence to address how an option will be implemented
por: Fretheim, Atle, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews
por: Lavis, John N, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review
por: Lewin, Simon, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_80bpf8se3dm0h58mvr9h299adr